DROXIA 6336 DROXIA 6336 Pill - purple capsule/oblong, 19mm
Generic Name: hydroxyurea
Pill with imprint DROXIA 6336 DROXIA 6336 is Purple, Capsule/Oblong and has been identified as Droxia 300 mg. It is supplied by Bristol-Myers Squibb.
Droxia is used in the treatment of Sickle Cell Anemia and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DROXIA 6336 DROXIA 6336
Droxia
- Generic Name
- hydroxyurea
- Imprint
- DROXIA 6336 DROXIA 6336
- Strength
- 300 mg
- Color
- Purple
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00003-6336
- Inactive Ingredients
-
citric acid monohydrate,
gelatin,
magnesium stearate,
sodium phosphate,
titanium dioxide,
D&C Red No. 28,
D&C Red No. 33,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
More about Droxia (hydroxyurea)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
Other brands
Hydrea, Siklos, Mylocel, Xromi
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
